Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R plus L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
Por:
Chic, N, Gonzalez-Farre, B, Pare, L, Pascual, T, Saura, C, Melia, CH, Munoz, M, Fernandez, P, Martinez, D, Sanfeliu, E, Braso-Maristany, F, Gonzalez-Farre, X, Oliveira, M, Gil-Gil, M, Celiz, P, Ciruelos, EM, Villagrasa, P, Gregori, JG and Prat, A
Publicada:
1 may 2020
Resumen:
Filiaciones:
Chic, N:
Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
Gonzalez-Farre, B:
Hosp Clin Barcelona, Pathol, Barcelona, Spain
Pare, L:
SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
Pascual, T:
SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
Saura, C:
Vall dHebron Univ Hosp, Inst Oncol, Dept Med Oncol, Barcelona, Spain
Melia, CH:
Hosp Clin Univ Valencia, Valencia, Spain
Munoz, M:
Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Dept Pathol, Badalona, Spain
Martinez, D:
August Pi & Sunyer Biomed Res Inst, Dept Sci Translat Genom & Targeted Therapet Solid, Barcelona, Spain
Sanfeliu, E:
Hosp Clin Barcelona, Pathol, Barcelona, Spain
Braso-Maristany, F:
IDIBAPS, Translat Genom & Targeted Therapeut Solid Tumors, Barcelona, Spain
Gonzalez-Farre, X:
Hosp Gen Cataluna, Dept Med Oncol, San Cugat Del Valles, Spain
Oliveira, M:
Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
Vall dHebron Inst Oncol, Barcelona, Spain
Gil-Gil, M:
Inst Catala Oncol, Dept Med Oncol, Lhospitalet De Llobregat, Spain
Celiz, P:
SOLTI Breast Canc Res Grp, Dept Sci, Barcelona, Spain
Ciruelos, EM:
Univ Hosp 12 Octubre, Dept Med Oncol, Madrid, Spain
Villagrasa, P:
SOLTI, Breast Canc Res Grp, Barcelona, Spain
Gregori, JG:
IVO Fdn Inst Valenciano Oncol, Dept Med Oncol, Valencia, Spain
Prat, A:
Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain
Bronze
|